Cargando…

Safety of the proposed amendment of the specifications for enzymatically produced steviol glycosides (E 960c): Rebaudioside D produced via enzymatic bioconversion of purified stevia leaf extract

The EFSA Panel on Food Additives and Flavourings (FAF Panel) provides a scientific opinion on the safety of a proposed amendment of the specifications of enzymatically produced steviol glycosides (E 960c) with respect to the inclusion of rebaudioside D produced via enzyme‐catalysed bioconversion of...

Descripción completa

Detalles Bibliográficos
Autores principales: Younes, Maged, Aquilina, Gabriele, Engel, Karl‐Heinz, Fowler, Paul J, Frutos Fernandez, Maria Jose, Fürst, Peter, Gürtler, Rainer, Gundert‐Remy, Ursula, Husøy, Trine, Manco, Melania, Mennes, Wim, Moldeus, Peter, Passamonti, Sabina, Shah, Romina, Waalkens‐Berendsen, Ine, Wright, Matthew, Barat Baviera, José Manuel, Degen, Gisela, Herman, Lieve, Leblanc, Jean‐Charles, Wölfle, Detlef, Aguilera, Jaime, Giarola, Alessandra, Smeraldi, Camilla, Vianello, Giorgia, Castle, Laurence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109230/
https://www.ncbi.nlm.nih.gov/pubmed/35600273
http://dx.doi.org/10.2903/j.efsa.2022.7291
_version_ 1784708861036331008
author Younes, Maged
Aquilina, Gabriele
Engel, Karl‐Heinz
Fowler, Paul J
Frutos Fernandez, Maria Jose
Fürst, Peter
Gürtler, Rainer
Gundert‐Remy, Ursula
Husøy, Trine
Manco, Melania
Mennes, Wim
Moldeus, Peter
Passamonti, Sabina
Shah, Romina
Waalkens‐Berendsen, Ine
Wright, Matthew
Barat Baviera, José Manuel
Degen, Gisela
Herman, Lieve
Leblanc, Jean‐Charles
Wölfle, Detlef
Aguilera, Jaime
Giarola, Alessandra
Smeraldi, Camilla
Vianello, Giorgia
Castle, Laurence
author_facet Younes, Maged
Aquilina, Gabriele
Engel, Karl‐Heinz
Fowler, Paul J
Frutos Fernandez, Maria Jose
Fürst, Peter
Gürtler, Rainer
Gundert‐Remy, Ursula
Husøy, Trine
Manco, Melania
Mennes, Wim
Moldeus, Peter
Passamonti, Sabina
Shah, Romina
Waalkens‐Berendsen, Ine
Wright, Matthew
Barat Baviera, José Manuel
Degen, Gisela
Herman, Lieve
Leblanc, Jean‐Charles
Wölfle, Detlef
Aguilera, Jaime
Giarola, Alessandra
Smeraldi, Camilla
Vianello, Giorgia
Castle, Laurence
collection PubMed
description The EFSA Panel on Food Additives and Flavourings (FAF Panel) provides a scientific opinion on the safety of a proposed amendment of the specifications of enzymatically produced steviol glycosides (E 960c) with respect to the inclusion of rebaudioside D produced via enzyme‐catalysed bioconversion of purified stevia leaf extract. Rebaudioside D (95% on dry basis) is produced via enzymatic bioconversion of purified stevia leaf extract using uridine diphosphate (UDP)‐glucosyltransferase (UGT) and sucrose synthase enzymes produced by the genetically modified yeast K. phaffii UGT‐A, that facilitates the transfer of glucose to purified stevia leaf extract via glycosidic bonds. The same enzymes from K. phaffii UGT‐A may be used in the manufacturing process of the food additive, rebaudioside M produced via enzyme modification of steviol glycosides from stevia (E 960c(i)). The Panel considered that separate specifications would be needed for this food additive produced via the manufacturing process described in the current application, aligned with those already established for E 960c(i). The Panel concluded that there is no toxicological concern for Rebaudioside D produced via enzymatic bioconversion of purified stevia leaf extract using UDP‐glucosyltransferase and sucrose synthase produced by a genetically modified strain of the yeast K. phaffii. However, based on the available data, the Panel could not exclude the possibility that some residual amount of DNA coding for the kanamycin resistance gene could remain in the final product. Should this gene propagate in microbiota due to the presence of recombinant DNA in the final product, this would be of concern. Therefore, the Panel concluded that the safety of Rebaudioside D produced via this enzymatic bioconversion was not sufficiently demonstrated with the available data given that the absence of recombinant DNA was not shown.
format Online
Article
Text
id pubmed-9109230
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-91092302022-05-20 Safety of the proposed amendment of the specifications for enzymatically produced steviol glycosides (E 960c): Rebaudioside D produced via enzymatic bioconversion of purified stevia leaf extract Younes, Maged Aquilina, Gabriele Engel, Karl‐Heinz Fowler, Paul J Frutos Fernandez, Maria Jose Fürst, Peter Gürtler, Rainer Gundert‐Remy, Ursula Husøy, Trine Manco, Melania Mennes, Wim Moldeus, Peter Passamonti, Sabina Shah, Romina Waalkens‐Berendsen, Ine Wright, Matthew Barat Baviera, José Manuel Degen, Gisela Herman, Lieve Leblanc, Jean‐Charles Wölfle, Detlef Aguilera, Jaime Giarola, Alessandra Smeraldi, Camilla Vianello, Giorgia Castle, Laurence EFSA J Scientific Opinion The EFSA Panel on Food Additives and Flavourings (FAF Panel) provides a scientific opinion on the safety of a proposed amendment of the specifications of enzymatically produced steviol glycosides (E 960c) with respect to the inclusion of rebaudioside D produced via enzyme‐catalysed bioconversion of purified stevia leaf extract. Rebaudioside D (95% on dry basis) is produced via enzymatic bioconversion of purified stevia leaf extract using uridine diphosphate (UDP)‐glucosyltransferase (UGT) and sucrose synthase enzymes produced by the genetically modified yeast K. phaffii UGT‐A, that facilitates the transfer of glucose to purified stevia leaf extract via glycosidic bonds. The same enzymes from K. phaffii UGT‐A may be used in the manufacturing process of the food additive, rebaudioside M produced via enzyme modification of steviol glycosides from stevia (E 960c(i)). The Panel considered that separate specifications would be needed for this food additive produced via the manufacturing process described in the current application, aligned with those already established for E 960c(i). The Panel concluded that there is no toxicological concern for Rebaudioside D produced via enzymatic bioconversion of purified stevia leaf extract using UDP‐glucosyltransferase and sucrose synthase produced by a genetically modified strain of the yeast K. phaffii. However, based on the available data, the Panel could not exclude the possibility that some residual amount of DNA coding for the kanamycin resistance gene could remain in the final product. Should this gene propagate in microbiota due to the presence of recombinant DNA in the final product, this would be of concern. Therefore, the Panel concluded that the safety of Rebaudioside D produced via this enzymatic bioconversion was not sufficiently demonstrated with the available data given that the absence of recombinant DNA was not shown. John Wiley and Sons Inc. 2022-05-16 /pmc/articles/PMC9109230/ /pubmed/35600273 http://dx.doi.org/10.2903/j.efsa.2022.7291 Text en © 2022 Wiley‐VCH Verlag GmbH & Co. KgaA on behalf of the European Food Safety Authority. https://creativecommons.org/licenses/by-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nd/4.0/ (https://creativecommons.org/licenses/by-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited and no modifications or adaptations are made.
spellingShingle Scientific Opinion
Younes, Maged
Aquilina, Gabriele
Engel, Karl‐Heinz
Fowler, Paul J
Frutos Fernandez, Maria Jose
Fürst, Peter
Gürtler, Rainer
Gundert‐Remy, Ursula
Husøy, Trine
Manco, Melania
Mennes, Wim
Moldeus, Peter
Passamonti, Sabina
Shah, Romina
Waalkens‐Berendsen, Ine
Wright, Matthew
Barat Baviera, José Manuel
Degen, Gisela
Herman, Lieve
Leblanc, Jean‐Charles
Wölfle, Detlef
Aguilera, Jaime
Giarola, Alessandra
Smeraldi, Camilla
Vianello, Giorgia
Castle, Laurence
Safety of the proposed amendment of the specifications for enzymatically produced steviol glycosides (E 960c): Rebaudioside D produced via enzymatic bioconversion of purified stevia leaf extract
title Safety of the proposed amendment of the specifications for enzymatically produced steviol glycosides (E 960c): Rebaudioside D produced via enzymatic bioconversion of purified stevia leaf extract
title_full Safety of the proposed amendment of the specifications for enzymatically produced steviol glycosides (E 960c): Rebaudioside D produced via enzymatic bioconversion of purified stevia leaf extract
title_fullStr Safety of the proposed amendment of the specifications for enzymatically produced steviol glycosides (E 960c): Rebaudioside D produced via enzymatic bioconversion of purified stevia leaf extract
title_full_unstemmed Safety of the proposed amendment of the specifications for enzymatically produced steviol glycosides (E 960c): Rebaudioside D produced via enzymatic bioconversion of purified stevia leaf extract
title_short Safety of the proposed amendment of the specifications for enzymatically produced steviol glycosides (E 960c): Rebaudioside D produced via enzymatic bioconversion of purified stevia leaf extract
title_sort safety of the proposed amendment of the specifications for enzymatically produced steviol glycosides (e 960c): rebaudioside d produced via enzymatic bioconversion of purified stevia leaf extract
topic Scientific Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109230/
https://www.ncbi.nlm.nih.gov/pubmed/35600273
http://dx.doi.org/10.2903/j.efsa.2022.7291
work_keys_str_mv AT safetyoftheproposedamendmentofthespecificationsforenzymaticallyproducedsteviolglycosidese960crebaudiosidedproducedviaenzymaticbioconversionofpurifiedstevialeafextract
AT younesmaged safetyoftheproposedamendmentofthespecificationsforenzymaticallyproducedsteviolglycosidese960crebaudiosidedproducedviaenzymaticbioconversionofpurifiedstevialeafextract
AT aquilinagabriele safetyoftheproposedamendmentofthespecificationsforenzymaticallyproducedsteviolglycosidese960crebaudiosidedproducedviaenzymaticbioconversionofpurifiedstevialeafextract
AT engelkarlheinz safetyoftheproposedamendmentofthespecificationsforenzymaticallyproducedsteviolglycosidese960crebaudiosidedproducedviaenzymaticbioconversionofpurifiedstevialeafextract
AT fowlerpaulj safetyoftheproposedamendmentofthespecificationsforenzymaticallyproducedsteviolglycosidese960crebaudiosidedproducedviaenzymaticbioconversionofpurifiedstevialeafextract
AT frutosfernandezmariajose safetyoftheproposedamendmentofthespecificationsforenzymaticallyproducedsteviolglycosidese960crebaudiosidedproducedviaenzymaticbioconversionofpurifiedstevialeafextract
AT furstpeter safetyoftheproposedamendmentofthespecificationsforenzymaticallyproducedsteviolglycosidese960crebaudiosidedproducedviaenzymaticbioconversionofpurifiedstevialeafextract
AT gurtlerrainer safetyoftheproposedamendmentofthespecificationsforenzymaticallyproducedsteviolglycosidese960crebaudiosidedproducedviaenzymaticbioconversionofpurifiedstevialeafextract
AT gundertremyursula safetyoftheproposedamendmentofthespecificationsforenzymaticallyproducedsteviolglycosidese960crebaudiosidedproducedviaenzymaticbioconversionofpurifiedstevialeafextract
AT husøytrine safetyoftheproposedamendmentofthespecificationsforenzymaticallyproducedsteviolglycosidese960crebaudiosidedproducedviaenzymaticbioconversionofpurifiedstevialeafextract
AT mancomelania safetyoftheproposedamendmentofthespecificationsforenzymaticallyproducedsteviolglycosidese960crebaudiosidedproducedviaenzymaticbioconversionofpurifiedstevialeafextract
AT menneswim safetyoftheproposedamendmentofthespecificationsforenzymaticallyproducedsteviolglycosidese960crebaudiosidedproducedviaenzymaticbioconversionofpurifiedstevialeafextract
AT moldeuspeter safetyoftheproposedamendmentofthespecificationsforenzymaticallyproducedsteviolglycosidese960crebaudiosidedproducedviaenzymaticbioconversionofpurifiedstevialeafextract
AT passamontisabina safetyoftheproposedamendmentofthespecificationsforenzymaticallyproducedsteviolglycosidese960crebaudiosidedproducedviaenzymaticbioconversionofpurifiedstevialeafextract
AT shahromina safetyoftheproposedamendmentofthespecificationsforenzymaticallyproducedsteviolglycosidese960crebaudiosidedproducedviaenzymaticbioconversionofpurifiedstevialeafextract
AT waalkensberendsenine safetyoftheproposedamendmentofthespecificationsforenzymaticallyproducedsteviolglycosidese960crebaudiosidedproducedviaenzymaticbioconversionofpurifiedstevialeafextract
AT wrightmatthew safetyoftheproposedamendmentofthespecificationsforenzymaticallyproducedsteviolglycosidese960crebaudiosidedproducedviaenzymaticbioconversionofpurifiedstevialeafextract
AT baratbavierajosemanuel safetyoftheproposedamendmentofthespecificationsforenzymaticallyproducedsteviolglycosidese960crebaudiosidedproducedviaenzymaticbioconversionofpurifiedstevialeafextract
AT degengisela safetyoftheproposedamendmentofthespecificationsforenzymaticallyproducedsteviolglycosidese960crebaudiosidedproducedviaenzymaticbioconversionofpurifiedstevialeafextract
AT hermanlieve safetyoftheproposedamendmentofthespecificationsforenzymaticallyproducedsteviolglycosidese960crebaudiosidedproducedviaenzymaticbioconversionofpurifiedstevialeafextract
AT leblancjeancharles safetyoftheproposedamendmentofthespecificationsforenzymaticallyproducedsteviolglycosidese960crebaudiosidedproducedviaenzymaticbioconversionofpurifiedstevialeafextract
AT wolfledetlef safetyoftheproposedamendmentofthespecificationsforenzymaticallyproducedsteviolglycosidese960crebaudiosidedproducedviaenzymaticbioconversionofpurifiedstevialeafextract
AT aguilerajaime safetyoftheproposedamendmentofthespecificationsforenzymaticallyproducedsteviolglycosidese960crebaudiosidedproducedviaenzymaticbioconversionofpurifiedstevialeafextract
AT giarolaalessandra safetyoftheproposedamendmentofthespecificationsforenzymaticallyproducedsteviolglycosidese960crebaudiosidedproducedviaenzymaticbioconversionofpurifiedstevialeafextract
AT smeraldicamilla safetyoftheproposedamendmentofthespecificationsforenzymaticallyproducedsteviolglycosidese960crebaudiosidedproducedviaenzymaticbioconversionofpurifiedstevialeafextract
AT vianellogiorgia safetyoftheproposedamendmentofthespecificationsforenzymaticallyproducedsteviolglycosidese960crebaudiosidedproducedviaenzymaticbioconversionofpurifiedstevialeafextract
AT castlelaurence safetyoftheproposedamendmentofthespecificationsforenzymaticallyproducedsteviolglycosidese960crebaudiosidedproducedviaenzymaticbioconversionofpurifiedstevialeafextract